Irobot Corporation (IRBT) 39.61 $IRBT iRobot's Business

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Irobot Corporation (IRBT) 39.61 $IRBT

iRobot's Business Initiatives Impressive, Risks Remain
Zacks Equity Research - Zacks Investment Research - Tue Aug 30, 7:08AM CDT
We issued an updated research report on premium appliances company iRobot Corporation (IRBT) on Aug 29, 2016.
HOLI: 21.32 (+0.03), ACCO: 10.12 (+0.12), ALRM: 27.88 (+0.45), IRBT: 39.61 (-0.25)

iRobot Expands Connected Product Line with Roomba® 960
PR Newswire - Thu Aug 04, 7:00AM CDT
iRobot Corp. (NASDAQ: IRBT), a leader in delivering robotic technology-based solutions, today announced the Roomba® 960 Vacuuming Robot starting at $699. The second 900 Series Roomba to be introduced by iRobot, Roomba® 960 extends mapping, adaptive navigation with visual localization and cloud connected app control to a wider range of consumers, providing high-efficiency and systematic cleaning at a more accessible price point. Further extending the company's connected product line, iRobot also announced iRobot HOME App availability for both existing and new Braava jet(TM) Mopping Robot customers.
IRBT: 39.61 (-0.25)

iRobot CEO to Speak at the Canaccord Genuity Annual Growth Conference
PR Newswire - Wed Aug 03, 7:30AM CDT
iRobot Corp. (NASDAQ: IRBT), a leader in delivering robotic technology-based solutions, today announced that Colin Angle, iRobot's chairman and chief executive officer, will discuss the company's achievements and financial outlook on Wednesday, August 10, 2016 at 10:00 a.m. ET at the Canaccord Genuity Annual Growth Conference being held in Boston, MA.
IRBT: 39.61 (-0.25)

Ideal Image to Appoint Deborah G. Ellinger as President and Chief Executive Officer
BusinessWire - Fri Jun 10, 7:30AM CDT
Ideal Image, the nation's largest multi-unit provider of aesthetic treatment services which allow men and women to look and feel their best without surgery, today announced their plan to appoint Deborah G. Ellinger as President and CEO. Ms. Ellinger will join the team later this month.
IRBT: 39.61 (-0.25)

iRobot Names Christian Cerda Chief Operating Officer
PR Newswire - Tue May 31, 3:01PM CDT
iRobot Corp. (NASDAQ: IRBT), a leader in delivering robotic technology-based solutions, today announced that as part of the company's strategic realignment to focus on the consumer market, it has appointed Christian Cerda as chief operating officer (COO). Cerda previously served as executive vice president and general manager of iRobot's Home Robots business unit. As COO, Christian will lead Global Commercial and Supply Chain Operations, overseeing manufacturing and supply chain in addition to marketing, sales and product management.
IRBT: 39.61 (-0.25)

iRobot's Business Initiatives Impress, Forex Risks a Drag
Zacks Equity Research - Zacks Investment Research - Tue May 31, 7:59AM CDT
We issued an updated research report on premium appliances company iRobot Corporation (IRBT) on May 30, 2016.
AMCX: 54.24 (-0.10), CPLA: 59.06 (+0.14), CRI: 95.84 (+0.55), IRBT: 39.61 (-0.25)

iRobot Announces Preliminary Results Of Annual Meeting Of Stockholders
PR Newswire - Wed May 25, 9:14AM CDT
iRobot Corp. (NASDAQ: IRBT), a leader in delivering robotic technology-based solutions, today announced that, based on the preliminary vote count provided by its proxy solicitor following the Company's 2016 Annual Meeting of Stockholders, shareholders have voted to elect iRobot's director nominees - Mohamad Ali and Michael Bell - to the iRobot Board of Directors.
IRBT: 39.61 (-0.25)

Leading Independent Proxy Advisory Firm Egan-Jones Recommends iRobot Shareholders Vote "FOR" ALL iRobot Director Nominees on WHITE Proxy Card
PR Newswire - Wed May 18, 1:53PM CDT
iRobot Corp. (NASDAQ: IRBT) ("iRobot" and the "Company", a leader in delivering robotic technology-based solutions, today announced that Egan-Jones Proxy Services ("Egan-Jones", an independent proxy voting and corporate governance firm, has recommended that iRobot shareholders vote "FOR" iRobot's highly-qualified and experienced director nominees - Mohamad Ali and Michael Bell - on the WHITE proxy card at the Company's Annual Meeting of Stockholders on May 25, 2016.
IRBT: 39.61 (-0.25)

Red Mountain Responds to iRobot's Chairman and Lead Director
BusinessWire - Wed May 18, 7:00AM CDT
--Leading proxy advisory firms, ISS and Glass Lewis, support Red Mountain's case for change by endorsing both of its independent and highly qualified nominees.
IRBT: 39.61 (-0.25)

Two Leading Independent Proxy Advisory Firms Recommend that iRobot Shareholders Vote for BOTH Red Mountain Nominees on the GREEN Proxy Card
BusinessWire - Mon May 16, 9:00AM CDT
--Both proxy advisory firms supported Red Mountain's case for change by endorsing both of its independent and highly qualified nominees.
IRBT: 39.61 (-0.25)

iRobot Chairman and CEO Mails Letter to Shareholders
PR Newswire - Mon May 16, 7:00AM CDT
iRobot Corp. (NASDAQ: IRBT), a leader in delivering robotic technology-based solutions, today announced that it has mailed the following letter to shareholders in connection with the Company's upcoming Annual Meeting of Stockholders to be held on May 25, 2016.
IRBT: 39.61 (-0.25)

Glass Lewis Recommends that iRobot Shareholders Vote for BOTH Red Mountain's Nominees on the GREEN Proxy
BusinessWire - Fri May 13, 7:10AM CDT
--Glass Lewis concludes, "Red Mountain has submitted the more compelling case to investors."
IRBT: 39.61 (-0.25)

iRobot Issues Open Letter to Shareholders
PR Newswire - Thu May 12, 7:14AM CDT
iRobot Corporation (NASDAQ: IRBT) ("iRobot" or the "Company", a leader in delivering robotic technology-based solutions, today issued the following open letter to iRobot shareholders from its Lead Independent Director, Deborah Ellinger, and recommended that iRobot shareholders vote FOR iRobot's highly-qualified and experienced director nominees - Mohamad Ali and Michael Bell - on the WHITE proxy card at the Company's Annual Meeting of Stockholders on May 25, 2016.
IRBT: 39.61 (-0.25)

iRobot Comments on ISS Recommendation
PR Newswire - Tue May 10, 9:37AM CDT
iRobot Corporation (NASDAQ: IRBT) ("iRobot" and the "Company", a leader in delivering robotic technology-based solutions, today issued the following statement in response to a report by Institutional Shareholder Services ("ISS" regarding the election of directors to iRobot's Board of Directors at iRobot's 2016 Annual Meeting of Stockholders to be held on May 25, 2016:
IRBT: 39.61 (-0.25)

ISS Recommends That iRobot Shareholders Vote for BOTH Red Mountain Nominees on the Green Proxy
BusinessWire - Tue May 10, 7:00AM CDT
--Red Mountain has "made a compelling case for change, and nominated candidates with skills and experience manifestly well-tailored to effecting the necessary change"
IRBT: 39.61 (-0.25)

Why iRobot Corporation Stock Popped Today
Steve Symington, The Motley Fool - Motley Fool - Wed Apr 27, 3:41PM CDT
iRobot's Roomba 980 continued to enjoy strong demand in Q1, Image source: iRobot Corporation What:  Shares of iRobot   climbed as much as 10.9% early Wednesday, and traded up 9.3% as of 3:30 p.m. EST after the home robot maker announced ...
IRBT: 39.61 (-0.25)

iRobot (IRBT) Q1 Earnings Top on Solid Home Robotics Trade
Zacks Equity Research - Zacks Investment Research - Wed Apr 27, 10:39AM CDT
iRobot Corporation (IRBT) reported better-than-expected results for first-quarter 2016.
CENT: 25.68 (unch), BDE: 4.65 (+0.05), CFI: 32.27 (+0.56), IRBT: 39.61 (-0.25)

iRobot Reports First-Quarter Financial Results
PR Newswire - Tue Apr 26, 3:01PM CDT
iRobot Corp. (NASDAQ: IRBT), a leader in delivering robotic technology-based solutions, today announced its financial results for the first quarter ended April 2, 2016.
IRBT: 39.61 (-0.25)

Will Q1 Earnings Hold a Surprise for iRobot (IRBT) Stock?
Zacks Equity Research - Zacks Investment Research - Fri Apr 22, 2:25PM CDT
Premium appliance company iRobot Corporation (IRBT) is scheduled to report first-quarter 2016 results on Apr 26, after the market closes.
RCL: 72.71 (+1.60), BYD: 19.73 (+0.23), SIX: 48.26 (-0.51), IRBT: 39.61 (-0.25)

iRobot Lead Independent Director Sends Letter To Shareholders
PR Newswire - Thu Apr 21, 6:00AM CDT
iRobot Corp. (NASDAQ: IRBT), a leader in delivering robotic technology-based solutions, today announced that iRobot has mailed a letter to shareholders from its Lead Independent Director, Deborah Ellinger, outlining the Board's approach to overseeing the Company's strategy, capital allocation, and R&D.
IRBT: 39.61 (-0.25)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

KINGRVER Boosts RV Comfort with New Water Heater Lineup

Updated Category News Views 9

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 123

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 52

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Updated Category News Views 422

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 175

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 104

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 0

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 432

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 287

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
YSTUDIO's Pens: A Nod to the Power of Writing

Updated Category News Views 557

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

Continue Reading

Top 5 Most Recently Viewed Articles

NKGen Biotech to Present Innovative Research at Global Congress

Updated Category News Views 157

NKGen Biotech's Exciting Announcement on Upcoming Presentation NKGen Biotech Inc. (NASDAQ: NKGN), a pioneering clinical-stage biotechnology firm dedicated to developing cutting-edge autologous and allogeneic natural killer cell therapies, has recently shared some thrilling news regarding their participation in an international event. Highlighting Neurodegenerative...

Continue Reading
Celebrating Case Managers: A Call to Action for 2025

Updated Category News Views 522

Recognizing the Contribution of Case Managers in 2025 Case managers have proven time and again to be essential contributors to the health and human services spectrum. In 2025, the two prominent organizations in the case management field—the American Case Management Association (ACMA) and the Commission for Case Manager Certification (CCMC)—have once again partnered to...

Continue Reading
Faruqi & Faruqi Investigates Ford Investor Claims

Updated Category News Views 92

Back in 2024, Faruqi & Faruqi took aim at Ford Motor Company (NYSE: F), investigating claims from investors who’d racked up losses over $100,000. They were diving deep into the financial mess at Ford—a colossal vehicle manufacturer that found itself knee-deep in allegations of breaching federal securities laws. The chatter was all about how quality assurance failures...

Continue Reading
Entourage Health Announces Going-Private Arrangement Plan

Updated Category News Views 236

Entourage Health Corp. Takes a Bold Step Toward Going-Private Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) has officially entered into a significant arrangement agreement with 1001007762 Ontario Inc. and 2437653 Ontario Inc. This strategic move, a statutory plan under the Business Corporations Act (Ontario), sees the Purchaser agreeing to acquire all common shares...

Continue Reading
A&W Revenue Royalties Income Fund Q3 2024 Results Review

Updated Category News Views 183

A&W Revenue Royalties Income Fund Q3 2024 Financial Overview TRADING SYMBOL: TSX: AW.UN A&W Revenue Royalties Income Fund has reported encouraging results for the third quarter ending this year. The quarterly performance reflects steady royalty income growth and strategic developments that promise an exciting future. Royalty Income Performance In the third quarter of...

Continue Reading